CLL arises from a CD5+ B lymphocyte expressing low levels of surface membrane immunoglobulin (smIg), a unique light chain, and the markers CD79b, CD20, and CD23. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.